Literature DB >> 9209493

Differential response of CD4+ V7+ and CD4+ V7- T cells to T cell receptor-dependent signals: CD4+ V7+ T cells are co-stimulation independent and anti-V7 antibody blocks the induction of anergy by bacterial superantigen.

L R Soares1, A Rivas, C Ruegg, E G Engleman.   

Abstract

V7 is a novel cell surface glycoprotein that is expressed on 25% of circulating T lymphocytes. This molecule appears to play a critical role in T cell activation based on the observation that a monoclonal anti-V7 antibody inhibits T cell receptor (TCR)-dependent interleukin-2 (IL-2) production and proliferation of T cells. In the current study, CD4+ V7+ and CD4+ V7- T cells were separated from one another and their response to various stimuli analyzed. Although there were only minor differences between the two subsets in the expression of activation/differentiation markers, including CD45RA and R0 isotypes, when exposed to immobilized anti-CD3 or anti-TCR antibodies in the absence of APC, CD4+ V7+ T cells alone produced IL-2 and proliferated vigorously. By contrast, CD4+ V7- cells responded poorly to such stimuli, but they recovered their capacity to respond if antigen-presenting cells (APC) or anti-CD28-antibody were added to the cultures. The enhancement of the V7- T cell response by APC appears to be related to augmentation of TCR signals because the effect could be blocked by antibodies against molecules on APC [major histocompatibility (MHC) class II, CD86] that are known to up-regulate such signals through their interaction with counter-receptors on T cells. To assess the role of V7 in a system independent of co-stimulation, CD4+ T cells were stimulated with the bacterial superantigens, staphylococcal enterotoxins A and B. The cells responded by proliferating and then becoming anergic. Addition of anti-V7 antibody at the initiation of culture with superantigen did not inhibit cellular proliferation but prevented T cells from becoming anergic, while addition of anti-CD28 antibody had no effect on either proliferation or anergy induction. These results indicate that V7 and CD28 mediate distinct intracellular signals and suggest that V7 functions to preserve T cell reactivity whether the stimulus is mitogenic or anergizing.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9209493     DOI: 10.1002/eji.1830270618

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  3 in total

1.  Synergistic effect of interleukin-2 and a vaccine of irradiated melanoma cells transfected to secrete staphylococcal enterotoxin A.

Authors:  David P Schrayer; Nicola Kouttab; Vincent J Hearing; Harold J Wanebo
Journal:  Clin Exp Metastasis       Date:  2002       Impact factor: 5.150

2.  Nucleotide substitutions in CD101, the human homolog of a diabetes susceptibility gene in non-obese diabetic mouse, in patients with type 1 diabetes.

Authors:  Misako Okuno; Yoshihito Kasahara; Masafumi Onodera; Noriyuki Takubo; Michiko Okajima; Shigeru Suga; Nobuyuki Watanabe; Junichi Suzuki; Tadayuki Ayabe; Tatsuhiko Urakami; Tomoyuki Kawamura; Nobuyuki Kikuchi; Ichiro Yokota; Toru Kikuchi; Shin Amemiya; Kazuhiko Nakabayashi; Keiko Hayashi; Kenichiro Hata; Yoichi Matsubara; Tsutomu Ogata; Maki Fukami; Shigetaka Sugihara
Journal:  J Diabetes Investig       Date:  2016-11-25       Impact factor: 4.232

3.  CD101 genetic variants modify regulatory and conventional T cell phenotypes and functions.

Authors:  Laura E Richert-Spuhler; Corinne M Mar; Paurvi Shinde; Feinan Wu; Ting Hong; Evan Greene; Sharon Hou; Katherine Thomas; Raphael Gottardo; Nelly Mugo; Guy de Bruyn; Connie Celum; Jared M Baeten; Jairam R Lingappa; Jennifer M Lund
Journal:  Cell Rep Med       Date:  2021-06-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.